Survival Advantage with Cardiovascular Drugs: Are they Real?
نویسندگان
چکیده
منابع مشابه
Herbal drug leaflets: are they in compliance with standards?
Leaflets inside pharmaceutical packages should include focal points about medicines being used by patients. The current study was designed to assess the compliance of information cited in herbal medicine leaflets with the standards released by the Ministry of Health and Medical Education of Iran (MHMEI). Leaflets of commonly used herbal pharmaceutical products sold in pharmacies of Iran were co...
متن کاملThe Single Nucleotide Polymorphisms in the C-reactive Protein Gene: are they Biomarkers of Cardiovascular Risk?
Recent pre-clinical and clinical studies have revealed the C-reactive protein gene (CRP) is related to the degree of acute rise in plasma C-reactive protein (CRP) levels. Moreover, single nucleotide polymorphisms (SNPs) in the CRP gene could associate with increased risk of cancer, atherosclerosis, diabetes mellitus, bowel disease, rheumatoid arthritis, psoriasis, obstructive pulmonary disease,...
متن کاملHerbal drug leaflets: are they in compliance with standards?
Leaflets inside pharmaceutical packages should include focal points about medicines being used by patients. The current study was designed to assess the compliance of information cited in herbal medicine leaflets with the standards released by the Ministry of Health and Medical Education of Iran (MHMEI). Leaflets of commonly used herbal pharmaceutical products sold in pharmacies of Iran were co...
متن کاملDrugs for Alzheimer's disease: are they effective?
OVERVIEW AD is a neurodegenerative process marked by neuronal loss and the deposition of abnormal proteins in the form of amyloid plaques and neurofibrillary tangles. Beta-amyloid deposition culminates in the production of extracellular amyloid plaques in the cerebral cortex and elsewhere in the central nervous system (CNS). Hyperphosphorylation of the intracellular tau protein results in neuro...
متن کاملGeneric oncology drugs: are they all safe?
Although the availability of generic oncology drugs allows access to contemporary care and reduces costs, there is international variability in the safety of this class of drugs. In this Series paper, we review clinical, policy, safety, and regulatory considerations for generic oncology drugs focusing on the USA, Canada, the European Union (EU), Japan, China, and India. Safety information about...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiovascular Pharmacology and Therapeutics
سال: 2003
ISSN: 1074-2484,1940-4034
DOI: 10.1177/107424840300800401